Description
The Nova StatStrip® Hospital Glucose Monitoring System is the only glucose meter system cleared by the FDA for use with critically ill patients. StatStrip Glucose has no known interferences and brings lab-like accuracy to bedside glucose testing—accuracy validated in an FDA submission study of 1,698 critically ill patients with 257 different and specific medical conditions, and over 8,000 medications, as well as over 137 published studies throughout the world. StatStrip Glucose measures glucose and corrects for hematocrit, Maltose, and other interferences that can cause erroneous results on other meters. Use of any other glucose meter with critically ill patients is considered off-label by the FDA.